sorafenib has been researched along with resminostat in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (resminostat) | Trials (resminostat) | Recent Studies (post-2010) (resminostat) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 20 | 6 | 19 |
| Protein | Taxonomy | sorafenib (IC50) | resminostat (IC50) |
|---|---|---|---|
| Histone deacetylase 1 | Homo sapiens (human) | 0.46 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.072 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammendola, AS; Bitzer, M; Cillo, U; Dollinger, MM; Ganten, TM; Gerken, G; Giannini, EG; Hauns, B; Henning, SW; Hentsch, B; Herz, T; Holzapfel, J; Horger, M; Lauer, UM; Mais, A; Malek, NP; Montesarchio, V; Pegoraro, S; Santoro, A; Scheulen, ME; Siveke, JT; Trevisani, F; Wege, H; Wörns, MA; Zagonel, V | 1 |
| Borgmann, M; Hamm, S; Hermann, F; Kallus, H; Parnitzke, U; Schrepfer, S; Streubel, G; Wulff, T | 1 |
1 trial(s) available for sorafenib and resminostat
| Article | Year |
|---|---|
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Hydroxamic Acids; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib; Sulfonamides | 2016 |
1 other study(ies) available for sorafenib and resminostat
| Article | Year |
|---|---|
Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Epithelial-Mesenchymal Transition; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Mice; Signal Transduction; Sorafenib; Sulfonamides | 2021 |